ZA201002997B - Fvii peptides and their use in tolerising haemophiliacs - Google Patents

Fvii peptides and their use in tolerising haemophiliacs

Info

Publication number
ZA201002997B
ZA201002997B ZA2010/02997A ZA201002997A ZA201002997B ZA 201002997 B ZA201002997 B ZA 201002997B ZA 2010/02997 A ZA2010/02997 A ZA 2010/02997A ZA 201002997 A ZA201002997 A ZA 201002997A ZA 201002997 B ZA201002997 B ZA 201002997B
Authority
ZA
South Africa
Prior art keywords
tolerising
haemophiliacs
fvii
peptides
fvii peptides
Prior art date
Application number
ZA2010/02997A
Other languages
English (en)
Inventor
David Wraith
Original Assignee
Apitope Tech (Bristol) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Tech (Bristol) Limited filed Critical Apitope Tech (Bristol) Limited
Publication of ZA201002997B publication Critical patent/ZA201002997B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2010/02997A 2007-12-04 2010-04-29 Fvii peptides and their use in tolerising haemophiliacs ZA201002997B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (1)

Publication Number Publication Date
ZA201002997B true ZA201002997B (en) 2011-07-27

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2010/02997A ZA201002997B (en) 2007-12-04 2010-04-29 Fvii peptides and their use in tolerising haemophiliacs

Country Status (25)

Country Link
US (1) US8445448B2 (enExample)
EP (1) EP2227488B3 (enExample)
JP (2) JP5501245B2 (enExample)
KR (1) KR101519840B1 (enExample)
CN (2) CN103709234B (enExample)
AU (1) AU2008332968B2 (enExample)
BR (1) BRPI0820143A2 (enExample)
CA (2) CA3005013C (enExample)
CY (1) CY1115168T1 (enExample)
DK (1) DK2227488T6 (enExample)
EA (1) EA019370B1 (enExample)
EC (1) ECSP10010327A (enExample)
ES (1) ES2458315T7 (enExample)
GB (1) GB0723712D0 (enExample)
HR (1) HRP20140344T4 (enExample)
IL (1) IL205780A (enExample)
MX (1) MX2010006084A (enExample)
MY (1) MY150995A (enExample)
NZ (1) NZ585217A (enExample)
PL (1) PL2227488T6 (enExample)
PT (1) PT2227488E (enExample)
SI (1) SI2227488T1 (enExample)
UA (1) UA101003C2 (enExample)
WO (1) WO2009071886A1 (enExample)
ZA (1) ZA201002997B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1311542T1 (sl) 2000-08-21 2009-02-28 Apitope Technology Bristol Ltd Tolerogenski peptidi
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
SI2300497T1 (sl) * 2008-06-24 2013-02-28 Octapharma Ag Postopek za äťiĺˇäťenje koagulacijskega faktorja viii
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
US20120135917A1 (en) * 2009-06-16 2012-05-31 Eisaku Yoshihara Anti-Gram Negative Bacteria Agent
DK2632479T3 (en) * 2010-10-27 2017-08-07 Baxalta GmbH FVIII PEPTIDES FOR IMMUNT TOLERANCE INDUCTION AND IMMUNODIAGNOSTICS
PL3453402T3 (pl) 2012-01-12 2022-03-21 Bioverativ Therapeutics Inc. Zmniejszenie immunogenności przeciwko czynnikowi viii u osób poddawanych terapii czynnikiem viii
PL2917232T3 (pl) * 2012-11-12 2017-09-29 Apitope International Nv Pochodzące od czynnika VIII peptydy do zastosowania w leczeniu hemofilii A
GB201314052D0 (en) 2013-08-06 2013-09-18 Apitope Int Nv Peptides
WO2017096329A1 (en) 2015-12-03 2017-06-08 Juno Therapeutics, Inc. Modified chimeric receptors and related compositions and methods
BR112019011198A2 (pt) 2016-12-02 2019-12-17 Bioverativ Therapeutics Inc métodos de indução de tolerância imune a fatores de coagulação
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT94427A (pt) 1989-06-20 1991-03-20 Scripps Clinic Res Processo para a preparacao de polipeptidos que inibem a ligacao de factor viii humano a fosfolipidos
BR9806793A (pt) * 1997-01-22 2000-05-16 Univ Texas Processos e composições de fator tissular para coagulação e tratamento de tumores.
SI1311542T1 (sl) * 2000-08-21 2009-02-28 Apitope Technology Bristol Ltd Tolerogenski peptidi
US20040096456A1 (en) * 2000-12-01 2004-05-20 Conti-Fine Bianca M Method to treat hemophilia
AU2002233340B2 (en) * 2001-02-19 2008-05-22 Merck Patent Gmbh Artificial fusion proteins with reduced immunogenicity
AU2002312660A1 (en) * 2001-05-31 2002-12-16 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
JP2005538694A (ja) * 2002-04-18 2005-12-22 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 修飾されたｖｉｉｉ因子
SI1729795T1 (sl) * 2004-02-09 2016-04-29 Human Genome Sciences, Inc. Albuminski fuzijski proteini
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
CN103709234A (zh) 2014-04-09
EP2227488A1 (en) 2010-09-15
DK2227488T3 (da) 2014-04-22
PL2227488T6 (pl) 2015-04-30
HRP20140344T1 (en) 2014-05-09
ES2458315T7 (es) 2015-02-18
EA019370B1 (ru) 2014-03-31
HK1144292A1 (en) 2011-02-11
AU2008332968B2 (en) 2014-03-20
ES2458315T3 (es) 2014-04-30
PT2227488E (pt) 2014-04-21
MX2010006084A (es) 2010-06-23
CA3005013C (en) 2021-11-16
DK2227488T6 (en) 2015-02-16
US20100323966A1 (en) 2010-12-23
WO2009071886A1 (en) 2009-06-11
CN101889024A (zh) 2010-11-17
AU2008332968A1 (en) 2009-06-11
EP2227488B1 (en) 2014-01-22
GB0723712D0 (en) 2008-01-16
US8445448B2 (en) 2013-05-21
JP6063402B2 (ja) 2017-01-18
JP5501245B2 (ja) 2014-05-21
CN103709234B (zh) 2017-01-18
HRP20140344T4 (hr) 2015-07-31
UA101003C2 (uk) 2013-02-25
EP2227488B3 (en) 2014-11-19
CY1115168T1 (el) 2016-12-14
BRPI0820143A2 (pt) 2015-05-12
KR20100087346A (ko) 2010-08-04
CA3005013A1 (en) 2009-06-11
KR101519840B1 (ko) 2015-05-18
CA2707559C (en) 2018-07-03
IL205780A0 (en) 2010-11-30
NZ585217A (en) 2012-11-30
MY150995A (en) 2014-03-31
PL2227488T3 (pl) 2014-07-31
IL205780A (en) 2015-06-30
CN101889024B (zh) 2014-04-23
JP2011505414A (ja) 2011-02-24
CA2707559A1 (en) 2009-06-11
JP2014088440A (ja) 2014-05-15
SI2227488T1 (sl) 2014-06-30
EA201070681A1 (ru) 2010-10-29
ECSP10010327A (es) 2010-09-30

Similar Documents

Publication Publication Date Title
ZA201002997B (en) Fvii peptides and their use in tolerising haemophiliacs
IL225740A (en) Polypeptides of (modified factor vii) and various aspects thereof
EP2262840A4 (en) METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
GB0702020D0 (en) Peptides and their use
ZA200807278B (en) Antibodies against human IL-22 and uses therefor
IL218776A0 (en) Modified factor vii polypeptides and uses thereof
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
GB0702021D0 (en) Peptides and their use
GB0702022D0 (en) Peptides and their use
PT2465523E (pt) Péptidos derivados de fviii e seu uso na tolerização de hemofílicos
IL236869A (en) Mark dhfr-puro and its use in protein production
GB0725153D0 (en) Protein analysis
IL211040A (en) Melanoma antigen peptide and uses
GB0607798D0 (en) Novel polypeptides and use thereof
GB0418421D0 (en) Improvements in and relating to testing
TWI367338B (en) Test device and program
GB0520309D0 (en) Improvements in and relating to flooring
EP2020417A4 (en) PROSTASIN PARTEPEPTIDE AND ANTI-PROSTASIN ANTIBODY
GB0617564D0 (en) Peptides and methods
GB0606866D0 (en) Improvements in and relating to analysis
GB0606666D0 (en) Improvements In And Relating To Analysis
GB0609833D0 (en) Improvements in and relating to analysis systems
GB0602244D0 (en) Peptide analysis
GB0417323D0 (en) Improvements in or relating to test systems or programs
GB0710813D0 (en) Peptides and uses thereof